New insulins and other possible therapeutic approaches

被引：3

作者：

Johannesen, J

Petersen, KF

Berger, M

Binder, C

机构：

[1] YALE UNIV,SCH MED,DEPT INTERNAL MED,NEW HAVEN,CT 06510

[2] UNIV DUSSELDORF,D-4000 DUSSELDORF,GERMANY

来源：

DIABETOLOGIA | 1997年 / 40卷 / Suppl 3期

关键词：

D O I：

10.1007/BF03168195

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：B89 / B93

页数：5

共 10 条

[1] INSULIN-LIKE GROWTH-FACTORS (IGFS) AND IGF-I TREATMENT IN THE ADOLESCENT WITH INSULIN-DEPENDENT DIABETES-MELLITUS
DUNGER, DB
CHEETHAM, TD
CROWNE, EC
[J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 1995, 44 (10): : 119 - 123
[2] Effect of 14 days' subcutaneous administration of the human amylin analogue, pramlintide (AC137), on an intravenous insulin challenge and response to a standard liquid meal in patients with IDDM
Kolterman, OG
Schwartz, S
Corder, C
Levy, B
Klaff, L
Peterson, J
Gottlieb, A
[J]. DIABETOLOGIA, 1996, 39 (04) : 492 - 499
[3] ULTRASOUND-MEDIATED TRANSDERMAL PROTEIN DELIVERY
MITRAGOTRI, S
BLANKSCHTEIN, D
LANGER, R
[J]. SCIENCE, 1995, 269 (5225) : 850 - 853
[4] Recombinant human insulin-like growth factor I increases insulin sensitivity and improves glycemic control in type II diabetes
Moses, AC
Young, SCJ
Morrow, LA
OBrien, M
Clemmons, DR
[J]. DIABETES, 1996, 45 (01) : 91 - 100
[5] Evidence based medicine: What it is and what it isn't - It's about integrating individual clinical expertise and the best external evidence
Sackett, DL
Rosenberg, WMC
Gray, JAM
Haynes, RB
Richardson, WS
[J]. BRITISH MEDICAL JOURNAL, 1996, 312 (7023) : 71 - 72
[6] THOMPSON RG, 1996, DIABETES S2, V45, pA222
[7] C-peptide revisited - New physiological effects and therapeutic implications
Wahren, J
Johansson, BL
WallbergHenriksson, H
Linde, B
FernqvistForbes, E
Zierath, JR
[J]. JOURNAL OF INTERNAL MEDICINE, 1996, 240 (03) : 115 - 124
[8] Diabetogenic effects of salmon calcitonin are attributable to amylin-like activity
Young, AA
Wang, MW
Gedulin, B
Rink, TJ
Pittner, R
Beaumont, K
[J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 1995, 44 (12): : 1581 - 1589
[9] BENEFICIAL METABOLIC EFFECTS OF INSULIN-LIKE GROWTH-FACTOR-I IN PATIENTS WITH SEVERE INSULIN-RESISTANT DIABETES TYPE-A
ZENOBI, PD
GLATZ, Y
KELLER, A
GRAF, S
JAEGGIGROISMAN, SE
RIESEN, WF
SCHOENLE, EJ
FROESCH, ER
[J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 1994, 131 (03) : 251 - 257
[10] Insulin lispro in CSII - Results of a double-blind crossover study
Zinman, B
Tildesley, H
Chiasson, JL
Tsui, E
Strack, T
[J]. DIABETES, 1997, 46 (03) : 440 - 443

← 1 →